In the last trading session, 1.0 million Vigil Neuroscience Inc (NASDAQ:VIGL) shares changed hands as the company’s beta touched 2.46. With the company’s per share price at $4.00 changed hands at -$2.67 or -40.03% during last session, the market valuation stood at $143.48M. VIGL’s last price was a discount, traded about -250.0% off its 52-week high of $14.00. The share price had its 52-week low at $4.68, which suggests the last value was -17.0% down since then. When we look at Vigil Neuroscience Inc’s average trading volume, we note the 10-day average is 0.13 million shares, with the 3-month average coming to 44.10K.
Analysts gave the Vigil Neuroscience Inc (VIGL) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.25. If we narrow down to specifics, the data shows that 0 out of 8 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended VIGL as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Vigil Neuroscience Inc’s EPS for the current quarter is expected to be -$0.53.
Vigil Neuroscience Inc (NASDAQ:VIGL) trade information
Instantly VIGL was in red as seen at the end of in last trading. With action -27.67%, the performance over the past five days has been red. The drop to weekly highs of 6.98 on Friday, 11/17/23 subtracted -40.03% to the stock’s daily price. The company’s shares are showing year-to-date downside of -68.00%, with the 5-day performance at -27.67% in the red. However, in the 30-day time frame, Vigil Neuroscience Inc (NASDAQ:VIGL) is -42.11% down. Looking at the short shares, we see there were 0.77 million shares sold at short interest cover period of 16.71 days.
Vigil Neuroscience Inc (VIGL) estimates and forecasts
Data shows that the Vigil Neuroscience Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -54.23% over the past 6 months, a 0.93% in annual growth rate that is considerably lower than the industry average of 14.90%. Moreover, analysts have looked to lower expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Vigil Neuroscience Inc will fall -10.40%, while the growth in revenue is estimated to hit -11.80% for the next quarter.
The 2023 estimates are for Vigil Neuroscience Inc earnings to increase by 2.49%.
Vigil Neuroscience Inc is expected to release its next quarterly earnings report in December.
Vigil Neuroscience Inc (NASDAQ:VIGL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 10.18% of Vigil Neuroscience Inc shares while 88.80% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 98.86%. There are 88.80% institutions holding the Vigil Neuroscience Inc stock share, with Atlas Venture Life Science Advisors, LLC the top institutional holder. As of Jun 29, 2023, the company held 16.27% of the shares, roughly 5.84 million VIGL shares worth $54.87 million.
Northpond Ventures, Llc holds the second largest percentage of outstanding shares, with 11.75% or 4.21 million shares worth $39.62 million as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 0.53 million shares estimated at $5.0 million under it, the former controlled 1.48% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 0.88% of the shares, roughly 0.32 million shares worth around $1.91 million.